A Phase 1/2 interventional study of OPLON active patch and Sham patch in Acne Vulgaris, sponsored by Oplon-Pure Science Ltd.. Completed at 1 site in Israel. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2010-08-11.
Sponsored by Oplon-Pure Science Ltd. · Phase 1/2, Interventional, and Treatment
The purpose of this study was to demonstrate the effect of short treatment with active OPLON patches on Acne.
Patients with Acne Vulgaris were treated overnight with active patches. Effect is observed at the end of the treatment and 24 hours later.
731 studies on the registry are indexed under Acne Vulgaris; 87 are open to participants now.
This study's enrollment of 35 is below the median of 69 across 629 interventional studies indexed under Acne Vulgaris.
Browse Acne Vulgaris studies →Oplon-Pure Science Ltd. is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: OPLON active patch
Device: Sham patch
Severity Score of lesion
Lesions were ranked by investigator according to severity whereas: 0-clear, 1-mild, 2-moderate, 3-sever
Time frame: •Severity Score of lesion [Time Frame: 24 hours following patch removal]
Severity Score of lesion
0-clear, 1-mild, 2-moderate, 3-sever
Time frame: •Severity Score of lesion [Time Frame: 12 hours with the patch]
This study is completed, as verified in Aug 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oplon-Pure Science Ltd.